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We report here the detailed characterisation of a non-
naturally occurring variant of human lysozyme, I59T,
which possesses a destabilising point mutation at the inter-
face of the a- and b-domains. Although more stable in its
native structure than the naturally occurring variants that
give rise to a familial form of systemic amyloidosis, I59T
possesses many attributes that are similar to these disease-
associated species. In particular, under physiologically
relevant conditions, I59T populates transiently an inter-
mediate in which a region of the structure unfolds coop-
eratively; this loss of global cooperativity has been
suggested to be a critical feature underlying the amyloido-
genic nature of the disease-associated lysozyme variants. In
the present study, we have utilised this variant to provide
direct evidence for the generic nature of the conformation-
al transition that precedes the ready formation of the
fibrils responsible for lysozyme-associated amyloid disease.
This non-natural variant can be expressed at higher levels
than the natural amyloidogenic variants, enabling, for
example, singly isotopically labelled protein to be gener-
ated much more easily for detailed structural studies by
multidimensional NMR spectroscopy. Moreover, we
demonstrate that the I59T variant can readily form fibrils
in vitro, similar in nature to those of the amyloidogenic
I56T variant, under significantly milder conditions than
are needed for the wild-type protein.
Keywords: fibril formation/human lysozyme/protein
misfolding/systemic amyloidosis
Introduction
The deposition, in a range of tissues and organs, of specific
proteins as aggregated species sharing a distinctive fibrillar
ultrastructure is a hallmark of an important family of protein
misfolding disorders, collectively known as amyloid diseases
(Chiti and Dobson, 2006). A variety of such disorders has
been identified, including organ-specific conditions such as
Alzheimer’s disease and type II diabetes, as well as the non-
neuropathic systemic amyloidoses associated with the pro-
teins transthyretin and lysozyme (Dobson, 1999). In the case
of the latter disorder, it was only in the early 1990s that two
single-point mutations (I56T and D67H) in human lysozyme
were found to be associated with this familial disease (Pepys
et al., 1993; Booth et al., 1997). More recently, other single-
point mutations (F57I and W64R) and two double mutations
(F57I/T70N and T70N/W112R) have also been linked to this
form of amyloidosis (Granel et al., 2002; Valleix et al.,
2002; Yazaki et al., 2003; Ro¨cken et al., 2005). Interestingly,
two naturally occurring mutations, T70N and W112R, have
been identified but do not appear to give rise to any manifes-
tation of disease (Booth et al., 2000; Yazaki et al., 2003).
Human lysozyme is a glycosidase which functions as an
antibacterial agent (Fleming, 1922). It contains 130 amino
acid residues, and in its native state, the protein possesses
four disulphide bonds and consists of two structural domains,
a predominantly helical region (the a-domain) and a region
containing significant b-sheet structure (the b-domain)
(Fig. 1A) (Artymiuk and Blake, 1981). Since their identifi-
cation, the I56T and D67H variants have been extensively
studied in vitro, revealing that amyloid formation arises from
a reduction, relative to wild-type (WT) lysozyme, both in
native state stability and in the global cooperativity of the
protein structure. These two mutations cause a similar
decrease in native stability (at pH 5.0, the midpoints of
thermal denaturation are 10+ 18C lower than for the WT
protein), and both the variants populate an effectively identi-
cal, partially unfolded intermediate under physiologically rel-
evant conditions (Canet et al., 1999; Takano et al., 2001a;
Canet et al., 2002; Dumoulin et al., 2005; Kumita et al.,
2006). In this transient species, the b-domain and the adja-
cent C-helix are simultaneously unfolded, whereas the
regions of the sequence that form helices A, B and D in the
remainder of the a-domain maintain significantly native-like
structure.
Biophysical analysis of the non-amyloidogenic T70N
variant reveals that it is destabilised relative to the WT
protein, but only by 4+ 18C, and under physiologically rel-
evant conditions, T70N does not detectably populate the par-
tially unfolded transient intermediate (Esposito et al., 2003;
Johnson et al., 2005). Interestingly, at elevated temperatures,
the transient intermediate can be significantly populated for
this variant as indeed it can, under even more extreme con-
ditions, for the WT protein. These observations indicate that
the species involved in this unfolding process, for all these
proteins, are closely related to the intermediate previously
observed in the folding of WT lysozyme (Hooke et al.,
# The Author 2010. Published by Oxford University Press. All rights reserved.
For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Page 1 of 8
Protein Engineering, Design & Selection pp. 1–8, 2010
doi:10.1093/protein/gzq023
 PEDS Advance Access published April 9, 2010
 at Bibliotheque Fac de M






Fig. 1. Location of mutations in human lysozyme and structural comparison of I59T lysozyme with the WT protein. (A) The location of the single-point
mutations are shown on the structure of human WT lysozyme, defined by X-ray diffraction (PDB entry 1REX). Known native amyloidogenic variants are
shown in red, the natural non-amyloidogenic single-point mutations, T70N and W112R, are shown in green and the non-natural I59T mutation, focused on in
this study, is shown in yellow. Disulphide bridges are shown as blue lines. The structure was produced using MolMol (Koradi et al., 1996). (B) Overlay of the
15N–1H HSQC spectra of the I59T (blue) and the WT protein (red) at pH 5.0, 378C in 90% 50 mM phosphate buffer and 10% 2H2O. The residues showing a
significant weighted difference in chemical shifts are labelled. (C) Perturbations in chemical shifts measured by NMR for the I59T variant compared with the
WT protein; (top) the differences in 15N chemical shift, Dd15N, (middle) differences in 1H chemical shift, Dd1H, and (bottom) weighted difference
, Dd .¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðDdð15NÞÞ2 þ ðDdð1HÞ  ðgð1HÞ=gð15NÞÞÞ2
q
; where g represents the gyromagnetic ratio of a given nuclei. Chemical shift changes of .0.1 ppm for
1H, 0.4 ppm for 15N and 0.1 ppm for ,Dd. are considered significant, and these boundaries are marked by dotted red lines.
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1994; Johnson et al., 2005). In order to understand in greater
detail the reasons that certain natural lysozyme variants
result in amyloid disease, it is important to probe the proper-
ties of non-natural variants.
In the previous work, the I59T variant was identified as
having a native state stability approximately mid-way
between the amyloidogenic variants and the WT protein
(Funahashi et al., 1999; Takano et al., 2001b; Kumita et al.,
2006). As the I59T mutation is located at the interface of the
a- and b-domains, where the naturally occurring amyloido-
genic variants I56T and F57I are located, we decided to
explore the biophysical characteristics of this non-natural
lysozyme variant to gain further insight into the mechanism
of in vitro lysozyme fibril formation. This study confirms
that the native state stability of the I59T variant is lower than
that of the WT protein at pH 5.0, interestingly, we have
found that this variant populates significantly a transient
intermediate species under physiologically relevant con-
ditions similar to that formed by the disease-associated var-
iants, and can also form fibrils in vitro under conditions
similar to those reported for the amyloidogenic variants,
I56T and D67H (Dumoulin et al., 2005).
Materials and methods
All chemicals and reagents were purchased from
Sigma-Aldrich UK unless otherwise stated.
Protein expression and purification
The I56T, I59T and WT human lysozymes were expressed
and purified as previously described (Spencer et al., 1999;
Johnson et al., 2005; Kumita et al., 2006) and a large scale
batch of I59T lysozyme was expressed in a 15 l fermentor at
the Protein Production and Characterization core facility of the
Centre for Protein Engineering (University of Lie`ge, http://
www.cip.ulg.ac.be/facilities.htm). 15N-labelled I59T lysozyme
was expressed in Pichia pastoris. Pre-cultures (6 ml) were
started in buffered minimal glycerol (BMG) media [100 mM
potassium phosphate, pH 6.0, 1.34% yeast nitrogen base
(YNB) with 10 g ammonium sulphate, 4  1025% biotin and
1% glycerol]. These cultures were incubated for 48 h (308C,
230 rpm) and a 1:100 dilution was made into 500 ml BMG and
incubated for 48 h (308C, 230 rpm). The BMG cultures
(250 ml) were centrifuged (5000g, 48C, 10 min) and the super-
natant was discarded. The yeast pellets were resuspended in
500 ml buffered minimal methanol media (100 mM potassium
phosphate, pH 6.0, 1.34% YNB with 5 g of 15N-labelled
ammonium sulphate, 4  1025% biotin and 0.5% methanol) to
induce protein expression and induction was performed for
72 h (308C, 230 rpm) with 0.5% methanol being replenished
every 12–24 h. After induction, the cultures were centrifuged
(9000g, 48C, 10 min) and the pellets were discarded. The
supernatant was then centrifuged a second time (9000g, 48C,
10 min) and filtered. Purification of lysozyme from the super-
natant was performed on an HS20 cation-exchange POROS
column (Applied Biosystems, Warrington, UK) on a Biocad
700E system (Applied Biosystems). Lysozyme was eluted at
55 mS by a linear NaCl gradient. The protein peaks were
analysed by SDS–PAGE and the relevant fractions were dia-
lysed against water for 48 h and then lyophilised. The purity of
proteins was confirmed by SDS–PAGE and molecular masses
were determined by electrospray ionisation mass spectrometry
(ESI-MS). For all proteins, stock solutions of lyophilised
material were made in Milli-Q water. Stock solutions were
passed through 0.22 mm pore size filters and concentrations
were determined by UV spectroscopy using an extinction coef-
ficient of 36 940 M21 cm21 at 280 nm for all variants in this
study; dilutions into appropriate buffers were made for each
assay.
NMR spectroscopy
15N-labelled I59T protein was prepared in 90% 50 mM phos-
phate buffer, 10% 2H2O and adjusted to pH 5.0. Spectra
were recorded at a protein concentration of 630 mM in a
Shigemi tube at 378C. 15N–1H resonance assignment for the
I59T variant was achieved by comparison with the known
assignments of the closely similar spectrum for the WT
protein (Ohkubo et al., 1991) and T70N variant (Johnson
et al., 2005) and supplemented by analysis of standard
3D-NMR experiments (15N–1H, HSQC-NOESY and
TOCSY) recorded on a Bruker Avance spectrometer at
700 MHz equipped with a TXI cryoprobe. Additionally,
HSQC spectra were recorded on a Bruker Avance spec-
trometer at 500 MHz equipped with a TCI cryoprobe. The
spectra were processed with NMRPipe (Delaglio et al.,
1995) and viewed with Sparky (http://www.cgl.ucsf.edu/
home/sparky/).
Real-time hydrogen/deuterium exchange experiments
Amide hydrogen exchange was monitored for the I59T
variant by 2D-NMR. 15N-labelled I59T sample was dissolved
in 550 ml of 20 mM acetic acid-d4 in
2H2O, pD 5, to a final
concentration of 350 mM and immediately placed in the
Bruker Avance 700 MHz NMR spectrometer that was pre-
tuned and shimmed with an equivalent sample. A series of
HSQC spectra were recorded over time. Hydrogen exchange
rates were measured from the reduction of peak volumes
over time. Protection factors were calculated from the ratio
of experimental rates to the predicted rates for a random coil
model based on the primary structure (Bai et al., 1993).
Ratios of amide protection factors for WT lysozyme were
compared with those for the I59T variant.
Thermal denaturation followed by circular dichroism
and fluorescence spectroscopy
Thermal denaturation was monitored by circular dichroism
(CD) spectroscopy at 222 nm (far-UV) and 270 nm
(near-UV) in a Jasco J-810 spectropolarimeter (JASCO Ltd,
Great Dunmow, UK). Samples were analysed using 0.1 and
1.0 cm path-length cells, respectively, with a protein concen-
tration of 13.6 mM [10 mM sodium citrate (pH 5.0)]. Far-UV
scans were recorded from 200 to 250 nm, and near-UV scans
were recorded from 250 to 350 nm; all scans were recorded
at 208C and the spectra reported are the average of five scans
each, with appropriate background spectra subtracted. A scan
speed of 50 nm min21, with a 1 nm bandwidth and a 4 s
response time, was used. For thermal denaturation, the temp-
erature was increased from 20 to 958C at a rate of
0.58C min21 and all experiments were performed in
triplicate.
Ellipticity values were normalised to the fraction of
unfolded protein (Fu) using Fu ¼ (u2 uN)/(uU2 uN), where
u is the observed ellipticity, uN the native ellipticity and uU
the unfolded ellipticity. uN and uU were extrapolated from
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pre- and post-transition baselines at the relevant temperature.
Experimental data were fitted to a sigmoidal expression
(Mombelli et al., 1997) using SigmaPlot 9.0 (Systat Software
UK Ltd, London, UK). Tm is defined as the temperature
where the fraction of unfolded protein is 0.5. Thermal dena-
turation monitored by 8-anilino-1-napthalenesulfonic acid
(ANS) fluorescence emission was recorded on a Cary
Eclipse spectrofluorimeter (Varian Ltd, Oxford, UK) using
excitation and emission wavelengths of 350 and 475 nm,
respectively, and slit-widths of 5 nm. The temperature was
increased from 20 to 958C at a rate of 0.58C min21 and the
analysis performed on 2.0 mM protein in 0.1 M sodium
citrate (pH 5.0), containing 360 mM ANS. Transition curves
of a control sample of ANS alone (360 mM) were collected
and subtracted from all samples to take into account the
effects of temperature on ANS fluorescence. The fluor-
escence data were normalised with respect to the emission
spectrum of ANS in the presence of the I56T variant.
Experimental data were fitted to a Gaussian expression using
SigmaPlot 9.0 (Systat Software UK Ltd). Tm ANS is defined
as the temperature where the intensity of the ANS fluor-
escence emission is at its maximum value.
Chemical denaturation monitored by intrinsic fluorescence
and far-UV CD
Preparation of the samples. The WT, I56T and I59T
proteins were incubated overnight at 258C in sodium phos-
phate buffer (50 mM, pH 6.5) in the presence of increasing
concentrations of guanidinium hydrochloride (GdnHCl).
The protein concentration was 1.6, 1.9 and 11 mM for WT,
I56T and I59T, respectively. The reversibility of unfolding
transitions was checked by diluting the samples from post-
transition (6 M) GdnHCl to pre-transition GdnHCl concen-
trations. Unfolding and refolding curves were determined by
monitoring the intrinsic fluorescence emission (for the three
proteins) and far-UV CD (only for the I59T variant) at 258C.
The final concentration of GdnHCl was determined by refrac-
tometry using [GdnHCl] ¼ 57.147(Dn) þ 38.68(Dn)22
91.60(Dn)3, where Dn is the difference between the refractive
indices of the GdnHCl solution and the 50 mM sodium phos-
phate buffer (Pace, 1986).
Fluorescence measurements. Intrinsic fluorescence emission
spectra were recorded on a Cary Eclipse spectrofluorimeter
(Varian Ltd) in a quartz ultra-micro-cell (Hellma UK Ltd,
Southend-On-Sea, UK) with a 1 cm path length. Both exci-
tation and emission slit widths were 5 mm, the scan speed
was 600 nm min21 and the photomultiplication was 800 V.
The excitation wavelength was 295 nm and emission spectra
were recorded from 300 to 440 nm; for each sample, five
spectra were accumulated and averaged. Fluorescence
spectrum of each sample was corrected for the background
fluorescence of the solution (buffer and denaturant).
Five fluorescence parameters have been considered in this
work: the fluorescence intensity at 340 and 360 nm, the ratio
of fluorescence intensities at 340 and 360 nm, the wavelength
corresponding to the maximum in fluorescence intensity
(lmax) and the centre of the spectral mass of the fluorescence
spectrum (csm) following a procedure previously published
(Dumoulin et al., 2002). The analysis based on these five
parameters resulted in similar values of thermodynamic par-
ameters, within the error limit, which were averaged to yield
the data in Table I.
CD measurements. CD measurements were performed with
a Jasco J-810 spectropolarimeter, using a 0.1 cm path-length
cell. GdnHCl unfolding curves were recorded at 222 nm. At
all denaturant concentrations, at least 30 data points were
acquired and averaged with a reading frequency of 0.1 s21, a
1 s integration time and a 1 nm bandwidth. The resulting
values were corrected for the contribution of the solvent.
Data analysis. The thermodynamic parameters for chemical
unfolding were computed on the assumption of a two-state
model for the unfolding reaction (NU). On this basis, the
transition curves were analysed according to the following
equation (Pace, 1990):
yobs ¼
ðyN þ p½DÞ þ ðyU þ q½DÞ exp½a
1 þ exp½a
where
a ¼ ðDG8ðH2OÞNU þ mNU½DÞ
RT
;
yobs is the measured variable parameter at a given denaturant
concentration, and yN and yU represent the values of this par-
ameter for the native and denatured states, respectively.
DG8(H2O)NU is the difference in free energy between the
folded and unfolded conformations, in the absense of dena-
turant; mNU is a measure of the dependence of the free
energy on the denaturant concentration and [D] the denatur-
ant concentration. p and q are the slopes of the pre- and post-
transition baselines, respectively, R the gas constant and T
the absolute temperature. The midpoint of the denaturation
curve is given by Cm ¼ DG8(H2O)/m. The fraction of





Table I. Biophysical characteristics of I59T compared with I56T and WT lysozymes
Lysozyme variant Tm (far-UV CD) Tm (near-UV CD) Tm ANS DG8(H2O)NU (kJ mol
21) m-value (kJ mol21 M21) Cm (M)
I56T 67.6+0.8a 66.0+1.0 65.6+0.9 32.0+3.4 213.2+1.2 2.4+0.1
I59T 71.0+1.0 69.9+1.0 71.0+0.7 39.3+3.3, 41.1+4.1b 213.1+0.7, 213.6+1.4b 3.0+0.1, 3.0+0.1b
WT 77.7+0.5 76.7+0.6 79.2+1.5a 66.4+3.0 217.2+0.5 3.9+0.1
aPreviously reported value under similar conditions (Kumita et al., 2006). All Tm values are measured in 8C.
bValue obtained from far-UV CD measurements.
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Hydrogen exchange monitored by ESI-MS
I56T and I59T variants were deuterated at exchangeable sites
by dissolving lyophilised protein (0.2 mg) in 2H2O (pH 3.8,
350 ml) and then heating the samples at 708C for 10 min.
After allowing the samples to cool to room temperature, they
were flash frozen in liquid N2 and lyophilised. Prior to per-
forming hydrogen/deuterium (H/D) exchange experiments,
the samples were dissolved in 2H2O to give protein concen-
trations of 200 mM. Samples were prepared by manual
mixing as described previously (Johnson et al., 2005) and
spectra were acquired over a mass/charge range of 500–
5000 Da on an LCT MS instrument (Waters Ltd, Elstree,
UK) equipped with a nanoflow Z-spray source and calibrated
with caesium iodide (CsI) (15 mM). The data were analysed
using MassLynx 4.0 (Waters Ltd) with molecular masses cal-
culated from the centroid values of at least three charge
states. The mass spectra shown represent the convolution of
three charged species with minimal smoothing and converted
to a mass scale. The per cent population of the intermediate
species was calculated using % intermediate species ¼
[(peak intensity of the intermediate species)/(peak intensity
of the intermediate species þ peak intensity of the native
species)]  100.
Aggregation monitored by right-angle light scattering
and thioflavin-T binding
Aggregation studies were performed with the I56T, I59T and
WT lysozyme variants [6.8 mM, 0.1 M sodium citrate buffer,
pH 5.0, and 62.5 mM thioflavin-T (Thio-T)] incubated with
stirring at 608C in a Cary Eclipse spectrofluorimeter (Varian
Ltd). Light scattering was monitored at 500 nm with slit
widths of 5 nm and Thio-T fluorescence was measured with
an excitation wavelength of 440 nm (slit width 5 nm) and
monitored at an emission wavelength of 480 nm (slit width
5 nm). All experiments were performed in triplicate.
Transmission electron microscopy
Samples were applied to Formvar-coated nickel grids,
stained with 2% (w/v) uranyl acetate solution and viewed in
a Philips CEM100 transmission electron microscope operat-
ing at 80 kV as described previously (Dumoulin et al.,
2003).
Results
As observed previously (Kumita et al., 2006), the expression
of I59T lysozyme in P. pastoris resulted in a significantly
higher yield of protein (1.7+ 0.3 mg l21) when compared
with the amyloidogenic variant, I56T (0.3+ 0.1 mg l21).
This enabled us to produce singly isotope-labelled 15N-I59T
lysozyme in the yeast expression system for multidimen-
sional NMR analysis. The crystal structure of I59T shows
that this variant, in its native state, is very similar to that of
the WT protein (Funahashi et al., 1999). Moreover, analysis
of I59T lysozyme by 1H–15N 2D-NMR shows that the WT
and I59T spectra overlay for most residues, with some vari-
ations in chemical shifts present in the vicinity of residue 59
and in the C-helix region (residues 90–100) (Fig. 1B and C).
Far-UV and near-UV CD indicates that the solution structure
of this variant also resembles closely that of the WT protein
(Supplementary Fig. S1A).
Thermal denaturation, monitored by CD spectroscopy, was
determined at pH 5.0; this pH is consistent with recently
reported in vitro fibril-forming conditions (Dumoulin et al.,
2005; Kumita et al., 2007). As previously demonstrated at
pH 2.7 (Funahashi et al., 1999), the Tm value at pH 5 for the
I59T variant is higher than that of the naturally occurring
amyloidogenic variant, I56T, but significantly lower (7+
18C) than that of the WT protein (Supplementary Fig. S1B;
Table I). We also monitored the GdnHCl-induced unfolding
of the I59T variant using intrinsic fluorescence and far-UV
CD (Supplementary Fig. 1C and D). The unfolding tran-
sitions obtained by each technique are highly cooperative
and occur with full thermodynamic reversibility (data not
shown). From these data, we calculated DG8(H2O)NU values
for the I59T variant of 39.3+ 3.3 and 41.1+ 4.1 kJ mol21
for fluorescence and far-UV CD, respectively. The superim-
position of the CD and fluorescence data after calculation of
the fraction of unfolded protein at all denaturant concen-
trations (Supplementary Fig. 1D) indicates that the secondary
and tertiary structures unfold simultaneously, i.e. the tran-
sition between native (N) and the unfolded (U) states occurs
without populating any intermediate structural states. For
comparison, we also measured the GdnHCl-induced unfold-
ing of the I56T and WT proteins by fluorescence measure-
ments (Supplementary Fig. 1C) and the thermodynamic
parameters calculated from these data are shown in Table I.
Our values of DG8(H2O)NU for I56T and WT lysozyme at
258C are comparable with those reported previously by
Esposito et al. (2003) for I56T and WT lysozyme at 208C
(27.1+ 0.7 and 57.3+ 5.7 kJ mol21, respectively).
By monitoring the ANS binding during thermal denatura-
tion, it has been previously observed that the amyloidogenic
variants show strong ANS binding at temperatures close to
their Tm values, whereas the WT protein shows very little
ANS binding (Dumoulin et al., 2005; Kumita et al., 2006).
Here, we observe an increase in ANS fluorescence emission
for the I59T variant due to the appearance of one or more
partially unfolded intermediates with solvent-exposed hydro-
phobic clusters (Fig. 2). This increase in emission signal is,
however, only about 60% of that seen for natural amyloido-
genic variant, I56T.
For the amyloidogenic variants, I56T and D67H, a par-
tially unfolded transient intermediate is detectable under
physiologically relevant conditions by H/D exchange, moni-
tored by mass spectrometry (Canet et al., 2002; Dumoulin
et al., 2005). In these experiments, the proteins are fully
deuterated and the exchange monitors the loss of deuterons
(as they are replaced by hydrogens) over time. For the amy-
loidogenic variants, two species have been detected in such
experiments; one of which can be attributed to the native
state, in which more deuterons are protected, and the other to
a species having less deuterons protected and represents the
molecules that have, at least once, formed the partially
unfolded intermediate species (Miranker et al., 1993; Canet
et al., 1999). There is considerable evidence that the for-
mation of such an intermediate is an important contributor to
the process of fibril formation by the amyloidogenic variants
of human lysozyme (Dumoulin et al., 2005; Chan et al.,
2008). It has been demonstrated, for example, that stabilis-
ation of the native state of these variants with camelid anti-
body fragments abolishes the formation of this intermediate,
and in addition, strongly inhibits in vitro fibril formation
A lysozyme variant with amyloidogenic attributes
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(Dumoulin et al., 2003, 2005; Chan et al., 2008). In addition,
neither the more stable T70N variant nor the WT protein dis-
plays a detectable intermediate under these conditions
(Johnson et al., 2005). We report here that the analogous
intermediate of I59T is readily detectable at 378C in the H/D
exchange experiment (Fig. 3A). The rate of formation of the
intermediate species for I59T is, however, slower than that of
the I56T variant with time constants (t) of 212.8+ 4.5 and
30.0+ 2.5 s, respectively (Fig. 3B).
H/D exchange can be monitored in a residue-specific
manner using 2D-NMR spectroscopy (Krishna et al., 2004).
In these experiments, the rates of exchange (from hydrogen
to deuteron) were determined at 378C and pD 5.0, and from
these rates, exchange protection factors were determined
based on the rate of exchange in the species being studied
relative to the rates of the same amide proton atoms in the
unstructured (random coiled) state (Mine et al., 2000). The
ratios of the protection factors for amides in I59T relative to
those in the WT protein were determined (Fig. 3C), and sig-
nificant changes in exchange rate as a consequence of the
I59T mutation are indicated as being greater than a 10-fold
increase. In a similar fashion to the amyloidogenic variants
(I56T and D67H), the region that displays the greatest
increase in exchange rates is located in the region of residues
39–84, which corresponds to the b-domain of the protein and
the region which has been shown to be unfolded in the transi-
ently partially unfolded intermediate (Canet et al., 2002). In
the I56T and D67H proteins, residues within the C-helix also
show increased exchange rates (Dumoulin et al., 2005),
whereas the I59T variant shows values that are increased by
,10-fold, indicating that this region is more stable in the
latter variant. From the mass spectrometry experiments, the
number of protected sites for the intermediate species of I56T
and I59T are identical (25+ 1, as determined at the time
point when the population of the native species and
Fig. 3. Appearance of the transient intermediate in lysozyme variants. (A)
Time points of H/D exchange reactions as monitored by mass spectrometry
for I56T (left panel) and I59T (right panel) at 378C. For the I56T and I59T
variants, a higher mass species dominates initially (at 20 and 45 s of
exchange, respectively). As time increases, the intensity of the lower mass
Fig. 2. Identification of partially unfolded intermediates as observed by
ANS fluorescence emission. Thermal denaturation as monitored by ANS
binding at pH 5.0. All the curves were normalised with respect to the
maximum fluorescence value (obtained at the Tm) of the I56T variant. As
the amyloidogenic variant, I56T (open triangles), unfolds, we observe a
strong ANS fluorescence emission at 475 nm at the temperature that
corresponds to the Tm of the protein. The I59T variant (open circles) shows
significant ANS signal (albeit not as intense as that of the I56T variant) and
the WT protein (filled squares) shows a much lower signal.
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intermediate species are similar in intensity), suggesting that
in this case, both the C-helix and the b-domain are unfolded;
however, the increased stability in the C-helix may explain
the slower rate of intermediate formation.
Finally, we wished to define the conditions under which
the I59T variant could form fibrils and whether such fibrils
are similar in morphology to those formed from one of the
amyloidogenic variants (I56T). Previously, lysozyme fibrils
have been formed in vitro under a number of different desta-
bilising conditions including elevated temperatures and low
pH, elevated temperatures and the presence of chemical
denaturants and for the amyloidogenic variants, and elevated
temperatures only at pH 5.0 (Morozova-Roche et al., 2000;
Dumoulin et al., 2003, 2005; Kumita et al., 2007; Frare
et al., 2009). Owing to the higher native state stability and
slower rate of transient intermediate formation for the I59T
variant, we investigated fibril formation with stirring at 608C,
pH 5.0. Light scattering, Thio-T binding and transmission
electron microscopy (TEM) confirm that the I59T variant
readily forms fibrillar species under these conditions at a
slightly slower rate of formation than the I56T variant
(Fig. 4). The resulting fibrils are structurally similar to those
observed for the I56T variant under the same conditions as
determined by TEM analysis (Fig. 4C). WT protein under
these conditions did not aggregate over the time course of
500 min. The ability of the I59T variant to form fibrils over
a time course of hours rather than days is extremely valuable
for probing important issues such as the ability of com-
pounds to inhibit this process (Kumita et al., 2007; Yerbury
et al., 2009). This allows us to study how biological factors
can influence fibril formation, thereby shedding light on how
living systems have evolved to deal with protein misfolding.
Discussion
Two key attributes have been found to be important for in
vitro fibril formation by the amyloidogenic variants, I56T
and D67H, namely a decrease in native state stability and a
loss in global cooperativity, both leading to the population of
a transient intermediate species (Dumoulin et al., 2003,
2005). This partially unfolded intermediate is not, in itself,
unique to the amyloidogenic variants; in fact, under destabi-
lising conditions (such as high temperatures or low pH), this
intermediate is detectable even for the WT protein (Johnson
et al., 2005). The I59T variant, examined in the present
study, like the disease-associated variants, possesses this
attribute under physiological conditions, albeit with a slower
rate of formation than the I56T variant. Moreover, the I59T
variant can reproducibly form fibrils on a relatively fast time
scale in vitro (t1/2 ¼ 170+ 40 min at 608C, pH 5.0) in the
absence of chemical denaturants, providing a valuable
assay for investigating factors which can alter fibril formation. Indeed, it has allowed us to study the inhibitory
effects of the extracellular chaperones, clusterin, haptoglobin
and a2-macroglobulin under conditions that do not perturb
the activity of these chaperones (Kumita et al., 2007;
Yerbury et al., 2009).
It is interesting that the I59T variant is more stable than
the I56T protein as the locations of these mutations are in a
similar region of the protein, completely buried in the
interior of the molecule. Analysis of the X-ray structures
shows, however, that the side-chain packing around Ile56 is
species increases; albeit at different rates for each variant. (B) The
populations of the intermediate states are plotted versus time to determine
the rate of formation of the transient intermediate. The time constant of
unfolding (t ¼ 1/k) for I56T (solid triangles) and I59T (open circles) are
30.0+2.5 and 212.8+4.5 s, respectively. (C) Ratios of amide protection
factors for the WT lysozyme compared with those of the I59T variant. The
broken line represents the value for which amide groups of the WT protein
have protection factors 10 times those of the I59T variant. A ratio of 1.0
represents an equal degree of protection in both proteins.
Fig. 4. In vitro fibril formation of I59T lysozyme. (A) Fibril formation
monitored by light scattering at 500 nm over time for I56T (filled triangles),
I59T (open circles) and WT protein (open squares) at 608C, pH 5.0. (B)
Thio-T fluorescence measured at various time points throughout the
light-scattering assay for I56T (black bars), I59T (light grey bars) and WT
(medium grey bars). (C) TEM analysis of samples taken at the end of the
growth phase observed in the light-scattering assay for I56T and I59T
variants. The scale bar represents 200 nm.
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tighter than that of Ile59; this suggests that the insertion of
different side chains may not be as easily accommodated
(Funahashi et al., 1999). Indeed, a cavity in the structure is
formed by the I56T mutation, whereas in I59T, a rearrange-
ment is observed in which the hydroxyl group of the intro-
duced threonine forms a hydrogen bond with a newly
introduce water molecule (Funahashi et al., 1999). Previous
studies have demonstrated that a water molecule in a cavity
created in the interior of lysozyme contributes favourably to
stability (Takano et al., 1997). Regardless of the origin of
the extra stability afforded to the I59T variant, its intermedi-
ate nature in terms of biophysical characteristics provides us
with a strategy through which we can begin to understand,
in vitro, the fundamental effects of mutations in the interface
region and to investigate the degree to which the loss of
native state stability and the ability to populate a transient
intermediate species is necessary to promote the amyloido-
genic character of certain lysozyme variants.
Supplementary data
Supplementary data are available at PEDS online.
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